Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,899 shares at $0.67 ($2K) on 2023-07-17, disclosed to the SEC on 2023-07-19.
Scheduled sale ($2k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 1,415 | $948 | 53.3% |
| 2 | $0.56 | 1,484 | $831 | 46.7% |
| Total | $0.61 avg | 2,899 | $2K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-17 | $1K | — | Filing → |